These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8690562

  • 21. Clinical trials of recombinant human DNase in cystic fibrosis patients.
    Aitken ML.
    Monaldi Arch Chest Dis; 1993 Dec; 48(6):653-6. PubMed ID: 8124306
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical development of rhDNase in the United States].
    Eisenberg J.
    Arch Pediatr; 1995 Jul; 2(7):674-8. PubMed ID: 7663659
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Dornase alpha and survival of patients with cystic fibrosis.
    McIntyre AM.
    Hosp Med; 1999 Oct; 60(10):736-9. PubMed ID: 10656067
    [Abstract] [Full Text] [Related]

  • 28. rhDNase in cystic fibrosis.
    Conway SP, Littlewood JM.
    Br J Hosp Med; 1999 Oct; 57(8):371-2. PubMed ID: 9274660
    [Abstract] [Full Text] [Related]

  • 29. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M, Dasgupta B, Tomkiewicz RP, Brown NE.
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [Abstract] [Full Text] [Related]

  • 30. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
    Suri R, Marshall LJ, Wallis C, Metcalfe C, Bush A, Shute JK.
    Am J Respir Crit Care Med; 2002 Aug 01; 166(3):352-5. PubMed ID: 12153969
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The clinical use of rhDNAse.
    Davies J, Trindale M, Wallis C, Rosenthal M, Bush A.
    Pediatr Pulmonol Suppl; 1997 Aug 01; 16():273-4. PubMed ID: 9443309
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
    Suri R, Wallis C, Bush A, Thompson S, Normand C, Flather M, Grieve R, Metcalfe C, Lees B.
    Health Technol Assess; 2002 Aug 01; 6(34):iii, 1-60. PubMed ID: 12583821
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
    Robinson M, Hemming AL, Moriarty C, Eberl S, Bye PT.
    Pediatr Pulmonol; 2000 Jul 01; 30(1):16-24. PubMed ID: 10862158
    [Abstract] [Full Text] [Related]

  • 39. Retrospective review of the effects of rhDNase in children with cystic fibrosis.
    Davies J, Trindade MT, Wallis C, Rosenthal M, Crawford O, Bush A.
    Pediatr Pulmonol; 1997 Apr 01; 23(4):243-8. PubMed ID: 9141109
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.